CD163 and follicular lymphoma: Controversial findings, as well as significant heterogeneity, have been reported regarding the contribution of CD163 expression in non-Hodgkin’s lymphoma disease activity, specifically in DLBCL, mantle cell lymphoma, follicular lymphoma, and T lymphoma [44,45].